Substance P signaling contributes to granuloma formation in taenia crassiceps infection, a murine model of cysticercosis

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Garza, Armandina ^a   Tweardy, David J ^a   Weinstock, Joel ^b   Viswanathan, Balaji ^a   Robinson, Prema ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROKININ 1 RECEPTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYSTICERCOSIS; CYTOKINE PRODUCTION; FEMALE; GRANULOMA; LUNG GRANULOMA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; TAENIA CRASSICEPS; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; TAENIA; TAENIASIS;

CESTODA; MURINAE; MUS; TAENIA CRASSICEPS; TAENIA SOLIUM;

ANIMALS; CYSTICERCOSIS; DISEASE MODELS, ANIMAL; FEMALE; GRANULOMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; RECEPTORS, NEUROKININ-1; SIGNAL TRANSDUCTION; SUBSTANCE P; TAENIA; TAENIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951920089     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/597086     Document Type: Article

References (47)

1. H. H. García, C. A. W. Evans, T. E. Nash, et al., "Current consensus guidelines for treatment of neurocysticercosis," Clinical Microbiology Reviews, vol. 15, no. 4, pp. 747-756, 2002. (Pubitemid 41184085)
2. A. Carpio, "Neurocysticercosis: an update," The Lancet Infectious Diseases, vol. 2, no. 12, pp. 751-762, 2002. (Pubitemid 35434561)
3. N. E. Bharucha, "Epidemiology of epilepsy in India," Epilepsia, vol. 44, supplement 1, pp. 9-11, 2003. (Pubitemid 36206000)
4. P. R. M. de Bittencourt, B. Adamolekum, N. Bharucha, et al., "Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy," Epilepsia, vol. 37, no. 11, pp. 1128-1137, 1996. (Pubitemid 26391247)
5. P. Jallon, "Epilepsy in developing countries," Epilepsia, vol. 38, no. 10, pp. 1143-1151, 1997. (Pubitemid 27424159)
6. V. Rajshekhar, D. D. Joshi, N. Q. Doanh, N. van De, and Z. Xiaonong, "Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues," Acta Tropica, vol. 87, no. 1, pp. 53-60, 2003. (Pubitemid 36637075)
7. A. L. Sánchez, J. Lindbäck, P. M. Schantz, et al., "A population-based, case-control study of Taenia solium taeniasis and cysticercosis," Annals of Tropical Medicine and Parasitology, vol. 93, no. 3, pp. 247-258, 1999. (Pubitemid 29355873)
8. S. Ong, D. A. Talan, G. J. Moran, et al., "Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments," Emerging Infectious Diseases, vol. 8, no. 6, pp. 608-613, 2002. (Pubitemid 34556362)
9. F. J. Sorvillo, S. H. Waterman, F. O. Richards, and P. M. Schantz, "Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County," American Journal of Tropical Medicine and Hygiene, vol. 47, no. 3, pp. 365-371, 1992.
10. B. I. Restrepo, P. Llaguno, M. A. Sandoval, J. A. Enciso, and J. M. Teale, "Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2," Journal of Neuroimmunology, vol. 89, no. 1-2, pp. 64-72, 1998. (Pubitemid 28389577)
11. O. F. Villa and R. E. Kuhn, "Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena," Parasitology, vol. 112, no. 6, pp. 561-570, 1996. (Pubitemid 26000515)
12. C. Larralde, R. M. Montoya, J. Sotelo, et al., "Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginat a bovine cysticercosis, and human E. granulosus hydatidosis," Bulletin de la Societe Francaise de Parasitology, vol. 8, p. S8B, 1990.
13. O. Villa and R. Kuhn, "Antigenic and immunogenic analysis of Taenia crassiceps and Taenia solium using sera from their natural intermediate hosts," ASM Bulletin, vol. 39, pp. 99-103, 1991.
14. J. Kunz, B. Kalinna, V. Watschke, and E. Geyer, "Taeni a crassiceps metacestode vesicular fluid antigens shared with the Taenia solium larval stage and reactive with serum antibodies from patients with neurocysticercosis," Zentralblatt für Bakteriologie, vol. 271, no. 4, pp. 510-520, 1989. (Pubitemid 19277427)
15. E. Sciutto, G. Fragoso, M. Baca, V. De la Cruz, L. Lemus, and E. Lamoyi, "Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection," Infection and Immunity, vol. 63, no. 6, pp. 2277-2281, 1995.
16. A. Garza, J. Weinstock, and P. Robinson, "Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection," Journal of Parasitology, vol. 94, no. 6, pp. 1253-1258, 2008.
17. P. Robinson, A. C. White, D. E. Lewis, J. Thornby, E. David, and J. Weinstock, "Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis," Infection and Immunity, vol. 70, no. 8, pp. 4534-4538, 2002. (Pubitemid 34790965)
18. S. Patil, J. Actor, P. Robinson, S. Baig, and A. J. White, "Proin-flammatory cytokines in murine cysticercal granulomas," in Proceedings of the 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH '99), Washington, DC, USA, November-December 1999.
19. T. S. Fröde-Saleh, J. B. Calixto, and Y. S. Medeiros, "Analysis of the inflammatory response induced by substance P in the mouse pleural cavity," Peptides, vol. 20, no. 2, pp. 259-265, 1999. (Pubitemid 29332108)
20. A. Hegde and M. Bhatia, "Neurogenic inflammation in acute pancreatitis," Journal of the Pancreas, vol. 6, no. 5, pp. 417-421, 2005. (Pubitemid 41574035)
21. K. A. Haines, S. L. Kolasinski, B. N. Cronstein, J. Reibman, L. I. Gold, and G. Weissmann, "Chemoattraction of neutrophils by substance P and transforming growth factor-β1 is inadequately explained by current models of lipid remodeling," The Journal of Immunology, vol. 151, no. 3, pp. 1491-1499, 1993. (Pubitemid 23219287)
22. C. M. Kahler, B. A. Sitte, N. Reinisch, and C. J. Wiedermann, "Stimulation of the chemotactic migration of human fibrob-lastsfd by substance P," European Journal of Pharmacology, vol. 249, no. 3, pp. 281-286, 1993. (Pubitemid 23334101)
23. P. Schratzberger, N. Reinisch, W. M. Prodinger, et al., "Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells," The Journal of Immunology, vol. 158, no. 8, pp. 3895-3901, 1997. (Pubitemid 127488749)
24. C. H. Smith, J. N. W. N. Barker, R. W. Morris, D. M. MacDonald, and T. H. Lee, "Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin," The Journal of Immunology, vol. 151, no. 6, pp. 3274-3282, 1993. (Pubitemid 23282640)
25. B. Veronesi, J. D. Carter, R. B. Devlin, S. A. Simon, and M. Oortgiesen, "Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line," Neuropeptides, vol. 33, no. 6, pp. 447-456, 1999. (Pubitemid 30110874)
26. K. Lieb, H. Schaller, J. Bauer, M. Berger, K. Schulze-Osthoff, and B. L. Fiebich, "Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6," Journal of Neurochemistry, vol. 70, no. 4, pp. 1577-1583, 1998. (Pubitemid 28136971)
27. B. L. Fiebich, S. Schleicher, R. D. Butcher, A. Craig, and K. Lieb, "The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kB," The Journal of Immunology, vol. 165, no. 10, pp. 5606-5611, 2000.
28. M. C. Cuesta, L. Quintero, H. Pons, and H. Suarez-Roca, "Substance P and calcitonin gene-related peptide increase IL-1/3, IL-6 and TNFα secretion from human peripheral blood mononuclear cells," Neurochemistry International, vol. 40, no. 4, pp. 301-306, 2002. (Pubitemid 34131603)
29. M. Lotz, J. H. Vaughan, and D. A. Carson, "Effect of neuropeptides on production of inflammatory cytokines by human monocytes," Science, vol. 241, no. 4870, pp. 1218-1221, 1988.
30. A. M. Blum, A. Metwali, M. Kim-Miller, et al., "The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni," The Journal of Immunology, vol. 162, no. 10, pp. 6080-6085, 1999. (Pubitemid 29314967)
31. D. L. Boros, "The role of cytokines in the formation of the schistosome egg granuloma," Immunobiology, vol. 191, no. 4-5, pp. 441-450, 1994. (Pubitemid 24331470)
32. K. Kasahara, K. Kobayashi, Y. Shikama, et al., "The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor-α to induce lung granulomas," Clinical Immunology and Immunopathology, vol. 51, no. 3, pp. 419-425, 1989. (Pubitemid 19149849)
33. H. M. S. Algood, P. L. Lin, and J. L. Flynn, "Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis," Clinical Infectious Diseases, vol. 41, supplement 3, pp. S189-S193, 2005. (Pubitemid 41022089)
34. A. A. Parikh, A. L. Salzman, C. D. Kane, J. E. Fischer, and P.-O. Hasselgren, "IL-6 production in human intestinal epithelial cells following stimulation with IL-1/3 is associated with activation of the transcription factor NF-kB," Journal of Surgical Research, vol. 69, no. 1, pp. 139-144, 1997. (Pubitemid 27265840)
35. K. Kurokouchi, F. Kambe, K. Yasukawa, et al., "TNF-α increases expression of IL-6 and ICAM-1 genes through activation of NF-kB in osteoblast-like ROS17/2.8 cells," Journal of Bone and Mineral Research, vol. 13, no. 8, pp. 1290-1299, 1998. (Pubitemid 28373331)
36. J. V. Weinstock, A. Blum, J. Walder, and R. Walder, "Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P," The Journal of Immunology, vol. 141, no. 3, pp. 961-966, 1988.
37. C. A. Maggi, "The effects of tachykinins on inflammatory and immune cells," Regulatory Peptides, vol. 70, no. 2-3, pp. 75-90, 1997. (Pubitemid 27362298)
38. W.-Z. Ho, J.-P. Lai, X.-H. Zhu, M. Uvaydova, and S. D. Douglas, "Human monocytes and macrophages express substance P and neurokinin-1 receptor," The Journal of Immunology, vol. 159, no. 11, pp. 5654-5660, 1997. (Pubitemid 127470097)
39. T. Goode, J. O'Connell, C. Sternini, et al., "Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononulear cells: molecular quantitation and localization," The Journal of Immunology, vol. 161, no. 5, pp. 2232-2240, 1998. (Pubitemid 28397034)
40. G. A. Cook, D. Elliott, A. Metwali, et al., "Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor," The Journal of Immunology, vol. 152, no. 4, pp. 1830-1835, 1994. (Pubitemid 24075715)
41. F. C. Martin, A. C. Charles, M. J. Sanderson, and J. E. Merrill, "Substance P stimulates IL-1 production by astrocytes via intracellular calcium," Brain Research, vol. 599, no. 1, pp. 13-18, 1992. (Pubitemid 23024911)
42. A. Azzolina, A. Bongiovanni, and N. Lampiasi, "Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells," Biochimica et Biophysica Acta, vol. 1643, no. 1-3, pp. 75-83, 2003. (Pubitemid 37494893)
43. A. Azzolina, P. Guarneri, and N. Lampiasi, "Involvement of p38 and JNK MAPKs pathways in substance P-induced production of TNF-α by peritoneal mast cells," Cytokine, vol. 18, no. 2, pp. 72-80, 2002. (Pubitemid 34754096)
44. A. Metwali, A. M. Blum, D. E. Elliott, T. Setiawan, and J. V. Weinstock, "Cutting edge: hemokinin has substance P-like function and expression in inflammation," The Journal of Immunology, vol. 172, no. 11, pp. 6528-6532, 2004. (Pubitemid 38669085)
45. J. M. Davis and L. Ramakrishnan, "The role of the granuloma in expansion and dissemination of early tuberculous infection," Cell, vol. 136, no. 1, pp. 37-49, 2009.
46. J. L. Stringer, L. M. Marks, A. C. White Jr., and P. Robinson, "Epileptogenic activity of granulomas associated with murine cysticercosis," Experimental Neurology, vol. 183, no. 2, pp. 532-536, 2003. (Pubitemid 37205095)
47. H. Liu, A. M. Mazarati, H. Katsumori, R. Sankar, and C. G. Wasterlain, "Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 9, pp. 5286-5291, 1999. (Pubitemid 29214575)